Work Area: Transactions

Latest content

Adeia licenses Kioxia and Western Digital to semiconductor portfolio

The new long-term agreements with both 3D NAND memory manufacturers includes Adeia's hybrid bonding rights

28 March 2023

New BlackBerry portfolio buyers have pedigree – but clock is ticking

The time and expense of launching an assertion programme in untested markets will limit the buyer’s ROI as well as incoming royalties

24 March 2023

WiLAN boosts 2022 licensing revenue 470% YOY thanks to big licences to Apple, others

Parent company Quarterhill is still undergoing a strategic review to determine whether to sell WiLAN, but doesn’t want the delay to remind anyone of the stagnant BlackBerry patent sale

22 March 2023

BlackBerry reveals new buyer and $200M deal - plus back-end royalties

The company has scrapped its failed $600 million deal with Catapult IP Innovations and now will seek US and Canadian government regulatory approval to close a $200 million pact

21 March 2023

SVB’s collapse is a reminder of how far IP finance still has to travel

Like many others, the bank held thousands of patents as security for loan deals, but almost certainly had no idea of their value – or lack of it

16 March 2023

Five patent takeaways from Pfizer’s $43 billion Seagen buyout

The takeover of the biopharma innovator is the largest pharma sector deal since 2019

14 March 2023

Global tax revolution will put corporate IP strategies under far greater scrutiny

New rules on transfer pricing drawn up by the OECD, which could be adopted by authorities in well over 100 countries, are set to have a major impact on how businesses manage their intangible assets

16 February 2023

Smartphone sales plummet causing pain for SEP licensors

Some licensing businesses hurt more than others and their basic deal structure is the differentiator

07 February 2023

Report finds ‘privateers’ charging royalties 15 times that of major SEP holders

Stout’s research identifies Panasonic, Nokia and Ericsson as the biggest sellers to privateers in the past decade

01 February 2023

What BioNTech’s £362 million AI acquisition says about the future of life sciences IP strategies

The convergence of tech and biopharma has major implications for patent professionals

13 January 2023

Unlock unlimited access to all IAM content